Boai NKY Medical Holdings Ltd. (SZSE: 300109)
Materials · Chemicals · CN
CN¥16.40
+19.10% today · +6.7% 1Y
Boai NKY Medical Holdings Ltd. (SZSE: 300109) operates in the Chemicals industry within the Materials sector. The company is valued at $1.42B and employs 1,186 people.
Over the last twelve months the share price has gained 6.7%, trading between 12.02 and 17.59.
Tweenvest scores Boai NKY Medical Holdings Ltd. across four factors: quality 73/100, value 19/100, growth 60/100, dividend 27/100. Its strongest factor is quality.
300109 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.42B
- Revenue (TTM)
- $173.29M
- P/E
- 55.71
- EPS
- 0.29
- Dividend yield
- 1.02%
- Beta (5Y)
- 0.24
- 52-week high
- CN¥17.59
- 52-week low
- CN¥12.02
- Avg volume (3M)
- —
- Shares outstanding
- 580.06M
- Employees
- 1,186
- Next earnings
- —
About Boai NKY Medical Holdings Ltd.
Boai NKY Medical Holdings Ltd. is an international enterprise specializing in the development, production, and global distribution of polyvinylpyrrolidone (PVP) series products. Its extensive product portfolio features pharmaceutical excipients such as Povidone, Crospovidone, and Copovidone, marketed under the KoVidone and PolyKoVidone brand lines. The company also manufactures OraRez PVM/MA copolymers and their derivatives, which are specialized functional polymers vital for bioadhesive and mucoadhesive applications. Additionally, it supplies KoVidone-1, a broad-spectrum agent with biocidal, antifungal, and antiviral efficacy. Further offerings encompass a wide array of chemical solutions, including pharmaceutical solvents, intermediates, various polymers, and vinyl and vinyl ether compounds. Specific branded products like PolyViscol, KoVidone I, WhiVidone, and PVPP are also part of their catalog. These diverse chemical components find integral application across numerous industries, including pharmaceuticals, industrial processes, oral care products, cosmetics, and the food and beverage sector. Founded in Heping, China, in 1987, the company was initially known as Boai NKY Pharmaceuticals Ltd. It transitioned to its current designation, Boai NKY Medical Holdings Ltd., in March 2016.
- ISIN
- CNE100000SV3
- Founded
- 1987
- Listed since
- Aug 25, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Chemicals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Linde plcNasdaqGS: LIN | $224.59B | $487.20 | -0.58% |
| L'Air Liquide S.A.ENXTPA: AI | $124.62B | €168.24 | +0.27% |
| The Sherwin-Williams CompanyNYSE: SHW | $84.57B | $350.45 | +1.07% |
| Ecolab Inc.NYSE: ECL | $81.17B | $289.54 | +0.89% |
| Shin-Etsu Chemical Co., Ltd.TSE: 4063 | $70.11B | ¥6,005.00 | -0.76% |
| Air Products and Chemicals, Inc.NYSE: APD | $67.66B | $303.85 | -0.78% |
| Corteva, Inc.NYSE: CTVA | $55.41B | $83.05 | +0.29% |
| BASF SEXTRA: BAS | $51.92B | €51.95 | +0.52% |
Figures last refreshed Aug 18, 2026.